PRELUDE CAPITAL MANAGEMENT, LLC - VTV THERAPEUTICS INC ownership

VTV THERAPEUTICS INC's ticker is VTVT and the CUSIP is 918385105. A total of 37 filers reported holding VTV THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of VTV THERAPEUTICS INC
ValueSharesWeighting
Q2 2017$57,000
-24.0%
11,3960.0%0.01%
-28.6%
Q1 2017$75,00011,3960.01%
Other shareholders
VTV THERAPEUTICS INC shareholders Q3 2017
NameSharesValueWeighting ↓
PIPER SANDLER & CO. 775,246$5,055,0005.40%
DAFNA Capital Management LLC 75,000$489,0000.48%
WALL STREET ASSOCIATES 244,000$1,591,0000.30%
SABBY MANAGEMENT, LLC 160,556$1,047,0000.04%
FARALLON CAPITAL MANAGEMENT LLC 250,000$1,630,0000.02%
Alyeska Investment Group, L.P. 126,951$828,0000.01%
Tower Research Capital LLC (TRC) 13,844$90,0000.01%
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 40,000$261,000,0000.01%
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC 356,866$2,327,0000.00%
FRANKLIN RESOURCES INC 952,900$6,213,0000.00%
View complete list of VTV THERAPEUTICS INC shareholders